Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Ocular Therapeutix, Inc changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 119 | 1 | 147 | +29 |
| Shares | 73.7M | 45.0K | 123.4M | +49.8M (+67.6%) |
| Value | $328.8M | $200.6K | $1.12B | +$792.7M (+241.2%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (47)
Institutions that held Ocular Therapeutix, Inc at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (18)
Institutions that held Ocular Therapeutix, Inc at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| StemPoint Capital LP | 279,648 | $1.25M |
| Balyasny Asset Management LLC | 89,000 | $396.9K |
| Virtu Financial LLC | 62,066 | $277.0K |
| Aristides Capital LLC | 50,226 | $224.0K |
| Cetera Advisors LLC | 46,527 | $207.5K |
| STRS Ohio | 38,200 | $170.0K |
| XTX Topco Ltd | 27,942 | $124.6K |
| Pegasus Partners Ltd. | 25,000 | $111.5K |
| Brevan Howard Capital Management LP | 20,121 | $89.7K |
| Sherbrooke Park Advisers LLC | 19,058 | $85.0K |
| Coastal Bridge Advisors, LLC | 12,900 | $57.5K |
| Dimensional Fund Advisors LP | 12,389 | $55.3K |
| River Wealth Advisors LLC | 10,000 | $44.6K |
| Covestor Ltd | 7,525 | $34.0K |
| Atlas Capital Advisors LLC | 5,000 | $22.3K |
| nVerses Capital, LLC | – | $12.5K |
| CWM, LLC | 2,000 | $9.00K |
| Gradient Investments LLC | 1 | $4 |
Not filed for Q1 2024 yet (1)
Institutions that held Ocular Therapeutix, Inc at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Sawtooth Solutions, LLC | 44,987 | $200.6K |